Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial
- PMID: 17101639
- DOI: 10.1001/jama.296.21.joc60162
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial
Abstract
Context: Poor medication adherence diminishes the health benefits of pharmacotherapies. Elderly patients with coronary risk factors frequently require treatment with multiple medications, placing them at increased risk for nonadherence.
Objective: To test the efficacy of a comprehensive pharmacy care program to improve medication adherence and its associated effects on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C).
Design, setting, and patients: A multiphase, prospective study with an observational phase and a randomized controlled trial conducted at the Walter Reed Army Medical Center of 200 community-based patients aged 65 years or older taking at least 4 chronic medications. The study was conducted from June 2004 to August 2006.
Intervention: After a 2-month run-in phase (measurement of baseline adherence, BP, and LDL-C), patients entered a 6-month intervention phase (standardized medication education, regular follow-up by pharmacists, and medications dispensed in time-specific packs). Following the intervention phase, patients were randomized to continued pharmacy care vs usual care for an additional 6 months.
Main outcome measures: Primary end point of the observation phase was change in the proportion of pills taken vs baseline; secondary end points were the associated changes in BP and LDL-C. Primary end point of the randomization phase was the between-group comparison of medication persistence.
Results: A total of 200 elderly patients (77.1% men; mean [SD] age, 78 [8.3] years), taking a mean (SD) of 9 (3) chronic medications were enrolled. Coronary risk factors included drug-treated hypertension in 184 patients (91.5%) and drug-treated hyperlipidemia in 162 (80.6%). Mean (SD) baseline medication adherence was 61.2% (13.5%). After 6 months of intervention, medication adherence increased to 96.9% (5.2%; P<.001) and was associated with significant improvements in systolic BP (133.2 [14.9] to 129.9 [16.0] mm Hg; P = .02) and LDL-C (91.7 [26.1] to 86.8 [23.4] mg/dL; P = .001). Six months after randomization, the persistence of medication adherence decreased to 69.1% (16.4%) among those patients assigned to usual care, whereas it was sustained at 95.5% (7.7%) in pharmacy care (P<.001). This was associated with significant reductions in systolic BP in the pharmacy care group (-6.9 mm Hg; 95% CI, -10.7 to -3.1 mm Hg) vs the usual care group (-1.0 mm Hg; 95% CI, -5.9 to 3.9 mm Hg; P = .04), but no significant between-group differences in LDL-C levels or reductions.
Conclusions: A pharmacy care program led to increases in medication adherence, medication persistence, and clinically meaningful reductions in BP, whereas discontinuation of the program was associated with decreased medication adherence and persistence.
Trial registration: clinicaltrials.gov Identifier: NCT00393419
Comment in
-
Challenges for improving medication adherence.JAMA. 2006 Dec 6;296(21):2614-6. doi: 10.1001/jama.296.21.jed60074. Epub 2006 Nov 13. JAMA. 2006. PMID: 17101641 No abstract available.
-
Pharmacy care programs and clinical outcomes.JAMA. 2007 Apr 25;297(16):1771-2; author reply 1772. doi: 10.1001/jama.297.16.1771. JAMA. 2007. PMID: 17456817 No abstract available.
Similar articles
-
Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.JAMA Intern Med. 2014 Feb 1;174(2):186-93. doi: 10.1001/jamainternmed.2013.12944. JAMA Intern Med. 2014. PMID: 24247275 Clinical Trial.
-
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.JAMA. 2013 Sep 4;310(9):918-29. doi: 10.1001/jama.2013.277064. JAMA. 2013. PMID: 24002278 Clinical Trial.
-
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318. BMJ. 2014. PMID: 24868083 Clinical Trial.
-
Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review.Clin Ther. 2011 Jan;33(1):62-73. doi: 10.1016/j.clinthera.2011.02.003. Clin Ther. 2011. PMID: 21397775 Review.
-
Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.Expert Rev Pharmacoecon Outcomes Res. 2024 Jan;24(1):143-154. doi: 10.1080/14737167.2023.2266135. Epub 2024 Jan 18. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 37862440 Review.
Cited by
-
Strategies to Improve Therapeutic Adherence in Polymedicated Patients over 65 Years: A Systematic Review and Meta-Analysis.Pharmacy (Basel). 2024 Feb 17;12(1):35. doi: 10.3390/pharmacy12010035. Pharmacy (Basel). 2024. PMID: 38392942 Free PMC article. Review.
-
Effect of aspirin on blood pressure in hypertensive patients: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 Feb 6;24(1):90. doi: 10.1186/s12872-024-03737-x. BMC Cardiovasc Disord. 2024. PMID: 38321368 Free PMC article.
-
Improving medication adherence in cardiovascular disease.Nat Rev Cardiol. 2024 Jun;21(6):417-429. doi: 10.1038/s41569-023-00972-1. Epub 2024 Jan 3. Nat Rev Cardiol. 2024. PMID: 38172243 Review.
-
Consumers' Willingness to Pay for Pharmacist Counselling Services and the Factors Affecting It in Community Pharmacies.Iran J Pharm Res. 2023 Apr 17;22(1):e132736. doi: 10.5812/ijpr-132736. eCollection 2023 Jan-Dec. Iran J Pharm Res. 2023. PMID: 38116550 Free PMC article.
-
Non-pharmacological fatigue interventions for patients with a primary brain tumour: a scoping review protocol.BMJ Open. 2023 Dec 14;13(12):e078183. doi: 10.1136/bmjopen-2023-078183. BMJ Open. 2023. PMID: 38101835 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical